# Biodesix (BDSX) — Earnings

BDSX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bdsx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.71 |
| EPS estimate | −$0.90 |
| EPS surprise | +21.27% |
| Revenue surprise | +3.21% |
| Revenue | $26.9M |
| Revenue estimate | $26.0M |
| Reported | Aug 5, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1439725/000119312526335036/bdsx-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/1fc9d23c-b44e-a961-59cf-d9b0036eb8c5.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 5, 2026 | −$0.90 | −$0.71 | 21.27% | $26.0M | $26.9M |
| Q1 2026 | May 4, 2026 | −$1.13 | −$0.81 | 28.31% | $23.1M | $25.6M |
| Q4 2025 | Feb 26, 2026 | −$0.86 | −$0.49 | 43.04% | $25.7M | $28.8M |
| Q3 2025 | Nov 3, 2025 | −$1.49 | −$1.16 | 22.15% | $21.0M | $21.8M |
| Q2 2025 | Aug 7, 2025 | −$1.38 | −$1.60 | -16.14% | $18.6M | $20.0M |
| Q1 2025 | May 13, 2025 | −$1.40 | −$1.60 | -14.64% | $19.4M | $18.0M |
| Q4 2024 | Mar 3, 2025 | −$1.34 | −$1.20 | 10.73% | $19.9M | $20.4M |
| Q3 2024 | Nov 1, 2024 | −$1.46 | −$1.40 | 4.29% | $18.6M | $18.2M |
| Q2 2024 | Aug 7, 2024 | −$1.84 | −$1.60 | 13.10% | $16.1M | $17.9M |
| Q1 2024 | May 8, 2024 | −$2.84 | −$2.80 | 1.50% | $14.2M | $14.8M |
| Q4 2023 | Mar 1, 2024 | −$2.18 | −$2.00 | 8.30% | $15.6M | $14.7M |
| Q3 2023 | Nov 7, 2023 | −$2.93 | −$2.80 | 4.54% | $14.1M | $13.5M |
| Q2 2023 | Aug 7, 2023 | −$4.12 | −$3.40 | 17.57% | $11.7M | $11.9M |
| Q1 2023 | May 11, 2023 | −$4.73 | −$4.80 | -1.41% | $8.7M | $9.1M |
| Q4 2022 | Mar 6, 2023 | −$5.55 | −$7.00 | -26.10% | $10.8M | $9.6M |
| Q3 2022 | Nov 3, 2022 | −$6.55 | −$6.80 | -3.77% | $10.2M | $11.1M |
| Q2 2022 | Aug 4, 2022 | −$9.30 | −$8.00 | 13.98% | $8.8M | $10.9M |
| Q1 2022 | May 11, 2022 | −$8.50 | −$10.00 | -17.65% | $6.5M | $6.5M |
| Q4 2021 | Mar 14, 2022 | −$9.84 | −$9.80 | 0.40% | $7.3M | $7.2M |
| Q3 2021 | Nov 15, 2021 | −$9.55 | −$8.20 | 14.14% | $6.2M | $6.5M |

## Frequently Asked Questions

### When did Biodesix (BDSX) last report earnings?

Biodesix last reported on Aug 5, 2026, covering fiscal Q2 2026.

### Did BDSX beat earnings estimates?

Yes. Biodesix reported EPS of −$0.71 for Q2 2026 against a −$0.90 estimate — a 21.27% beat.

### How much revenue did BDSX report last quarter?

Biodesix reported $26.9M in revenue for Q2 2026, against a consensus estimate of $26.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).